WHO approved trials for two new Ebola vaccines targeting the Bundibugyo strain.
The outbreak in the DRC has caused over 5,300 deaths since May.
The new vaccines were developed by Oxford, the Serum Institute of India, and Moderna.
A British healthcare worker infected with Ebola is being evacuated to the UK.
Read the full story on NexVani Media